Jupiter Topco LLC purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 39,710 shares of the company’s stock, valued at approximately $1,172,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC grew its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN raised its stake in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares in the last quarter. Allworth Financial LP bought a new stake in Acadia Healthcare during the second quarter worth about $45,000. Global Retirement Partners LLC acquired a new stake in Acadia Healthcare during the second quarter worth about $68,000. Finally, Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 4,264.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after buying an additional 5,203 shares in the last quarter.
Acadia Healthcare Trading Down 0.9%
Shares of ACHC stock opened at $28.13 on Friday. The firm has a market capitalization of $2.62 billion, a P/E ratio of -2.26, a P/E/G ratio of 9.06 and a beta of 0.62. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock’s fifty day simple moving average is $30.70 and its 200 day simple moving average is $26.51.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. UBS Group boosted their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Barclays lifted their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. TD Cowen boosted their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Jefferies Financial Group raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, Guggenheim lifted their price target on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and an average target price of $29.85.
View Our Latest Research Report on Acadia Healthcare
About Acadia Healthcare
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Read More
- Five stocks we like better than Acadia Healthcare
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
